Skip to content
Sign in
StableHealthReported 2026-11-12 23:30

Eli Lilly's GLP-1 Weight-Loss Pill Approved in China

Eli Lilly becomes the first drugmaker to have a GLP-1 weight-loss pill approved in China, giving it an early market lead over competitors like Novo Nordisk.

In depthRead the in-depth story

Why it matters. Eli Lilly gains an early market advantage in China's growing obesity treatment market, potentially increasing its share of the oral obesity treatment market.

01

Evidence

  • GGDELT Global Knowledge GraphMedia2026-11-12 23:30
    View source
  • GGDELT Global Knowledge GraphMedia2026-11-13 01:30
    View source
  • SSouth China Morning Post worldMedia2026-11-13 09:01
    View source
  • MMedical XpressMedia2026-11-13 18:20
    View source